ArticleDiagnostics (Basel, Switzerland)2021

Evaluation of Complete Pathological Regression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients with BRCA1 Founder Mutation Aided Bayesian A/B Testing Approach.

Piotr Kedzierawski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.